Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

(2020) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Lower irisin levels in coronary artery disease: a meta-analysis

(2020) Wenwen Guo et al.   Minerva Endocrinologica

Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The MUSCLES ‐ DM study

(2019) Ken Sugimoto et al.   Journal of Diabetes Investigation

The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore

(2019) Serena Low et al.   CLINICAL NUTRITION

OUP accepted manuscript

(2018)   AGE AND AGEING

Sarcopenia: a chronic complication of type 2 diabetes mellitus

(2018) Heloísa Trierweiler et al.   Diabetology & Metabolic Syndrome

OUP accepted manuscript

(2018)   AGE AND AGEING

Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices

(2017) A Bosy-Westphal et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study

(2017) Jae Seung Chang et al.   Geriatrics & Gerontology International

Frailty and sarcopenia - newly emerging and high impact complications of diabetes

(2017) Alan J. Sinclair et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients

(2017) Zeynel Abidin Öztürk   Turkish Journal of Physical Medicine and Rehabilitation

Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis

(2017) J. Xiao et al.   CLINICAL NUTRITION

Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus

(2016) Anthony P. Liccini et al.   Journal of the American Medical Directors Association

Association of anthropometric measures with fat and fat-free mass in the elderly: The Rotterdam study

(2016) Klodian Dhana et al.   MATURITAS

Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells

(2015) M. Hjorth et al.   Acta Physiologica

Sarcopenia – The search for emerging biomarkers

(2015) Alexander Kalinkovich et al.   AGEING RESEARCH REVIEWS

Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues

(2015) J Dong et al.   INTERNATIONAL JOURNAL OF OBESITY

Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus

(2015) Bo Kyung Koo et al.   Journal of Diabetes Investigation

Lean Mass, Muscle Strength and Gene Expression in Community Dwelling Older Men: Findings from the Hertfordshire Sarcopenia Study (HSS)

(2014) Harnish P. Patel et al.   CALCIFIED TISSUE INTERNATIONAL

Association of Low Muscle Mass and Combined Low Muscle Mass and Visceral Obesity with Low Cardiorespiratory Fitness

(2014) Tae Nyun Kim et al.   PLoS One

Association of Serum Irisin with Metabolic Syndrome in Obese Chinese Adults

(2014) Bing Yan et al.   PLoS One

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Effects of obesity, diabetes and exercise onFndc5gene expression and irisin release in human skeletal muscle and adipose tissue:in vivoandin vitrostudies

(2013) Timea Kurdiova et al.   JOURNAL OF PHYSIOLOGY-LONDON

Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults—an alternative measurement of sarcopenia and sarcopenic obesity

(2012) Tung Wai Auyeung et al.   AGE

Sarcopenic obesity: A Critical appraisal of the current evidence

(2012) C.M.M. Prado et al.   CLINICAL NUTRITION

Increased circulating myostatin in patients with type 2 diabetes mellitus

(2012) Fang Wang et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis

(2011) Der-Sheng Han et al.   CLINICAL ENDOCRINOLOGY

Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)

(2010) S. Lim et al.   DIABETES CARE

Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)

(2010) T. N. Kim et al.   DIABETES CARE

Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes

(2009) S. W. Park et al.   DIABETES CARE

Elevated Serum Advanced Glycation End Products and Poor Grip Strength in Older Community-Dwelling Women

(2009) M. Dalal et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese Women

(2008) D. S. Hittel et al.   DIABETES